depatuxizumab (ABT-806) / Life Science Pharma, AbbVie  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
depatuxizumab (ABT-806) / AbbVie
PANGEA-IMBBP, NCT02213289: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

Completed
2
80
US
Trastuzumab, Herceptin®, ABT-806, Bemarituzumab, Ramucirumab, Cyramza, Nivolumab, Opdivo, Standard cytotherapy
University of Chicago, AbbVie
Adenocarcinoma
02/20
08/20

Download Options